Identification of a 2-D geometric descriptor associated with non-genotoxic carcinogens and some estrogens and antiestrogens

Mutagenesis

Volumn 11, Issue 1, 1996, Pages 95-100

  Rosenkranz, Herbert S ^a   Cunningham, Albert ^a   Klopman, Gilles ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN; ESTROGEN RECEPTOR;

ARTICLE; CARCINOGENICITY; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; BINDING SITES; CARCINOGENS; ESTROGEN ANTAGONISTS; ESTROGENS; EXPERT SYSTEMS; MICE; MODELS, CHEMICAL; MOLECULAR STRUCTURE; MUTAGENS; RECEPTORS, ESTROGEN; SOFTWARE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030034955     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/11.1.95     Document Type: Article

References (39)

1. Ashby,J. (1992) Use of short-term tests in determining the genotoxicity or non-genotoxicity of chemicals. In Vainio,H., Magee,P.N., McGregor,D.B. and McMichael,A.J. (eds), Mechanisms of Carcinogenesis in Risk Identification, IARC Scientific Publication no. 116. International Agency for Research on Cancer, Lyon, pp. 135-164.
2. Ashby,J. (1994) Two million rodent carcinogens? The role of SAR and QSAR in their detection. Mutat. Res., 305, 3-12.
3. Ashby,J and Morrod,R.S. (1991) Detection of human carcinogens. Nature, 352, 185-186.
4. Ashby,J. and Tennant,R.W. (1991) Definitive relationships among chemical structure, carcinogenicity and mutagenicity of 301 chemicals tested by the U.S. National Toxicological Program. Mutat. Res., 257, 229-306.
5. Barrett,J.C (1992) Mechanisms of action of known human carcinogens. In Vainio,H., Magee,P.N., McGregor,D.B. and McMichael,A.J. (eds), Mechanisms of Carcinogenesis in Risk Identification, IARC Scientific Publication no. 116. International Agency for Research on Cancer, Lyon, pp. 115-134.
6. Bartsch,H. and Malaveille,C. (1989) Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC Monograph Senes. Cell Biol. Toxicol., 5, 115-127.
7. Black,L.J. and Goode,R.L. (1981) Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms. Endocrinology, 109, 987-989.
8. Brown,L.P. and Ashby,J. (1990) Correlations between bioassay dose-level, mutagenicity to Salmonella, chemical structure and sites of carcinogenesis among 226 chemicals evaluated by the U.S. NTP. Mutat. Res., 244, 67-76.
9. Coradini,D., Biffi,A., Cappelletti,V. and Di Fronzo,G. (1994) Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells. Anticancer Res., 14, 1059-1064.
10. Cunningham,A. and Rosenkranz,H.S. (1994) A study of the structural basis of the carcinogenicity of genotoxic and non-genotoxic molecules: diethylstilbestrol and metabolites - Part II. Technical Report no. CEOHT-94-11 to National Defense Center for Environmental Excellence. Available from World Wide Web: http://www.pitt.edu/~ jyzhang/ctc.html.
11. Cunningham,A. and Rosenkranz,H.S. (1995) A study of the carcinogenicity of xenoestrogens: metabolites of tamoxifen and toremifene. Technical Report no. CEOHT-95-01 to National Defense Center for Environmental Excellence. Available from World Wide Web: http://www.pitt.edu/~jyzhang/ctc.html.
12. Davis,D.L., Bradlow,H.L., Wolff,M., Woodruff,T., Hoel,D.G. and Anton-Culver,H. (1993) Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ. Hlth Perspect , 101, 372-377.
13. Gladek,A. and Liehr,J.G. (1989) Mechanism of genotoxicity of diethylstilbestrol in vivo. J. Biol. Chem., 264, 16847-16852
14. Ennever,F.K., Noonan,T.J. and Rosenkranz,H.S. (1987) The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans. Mutagenesis, 2, 73-78
15. Gold,L.S., Sawyer,C.B., Magaw,R., Backman,G.M., deVeciana,M., Levinson, R., Hooper,N.K., Havender,W.R., Berstein,L., Peto,R., Pike,M.C. and Ames,B.N. (1984) A carcinogenic potency database of the standardized results of animal bioassays. Environ. Hlth Perspect., 58, 9-319.
16. Gold,L.S., deVeciana,M., Backman,G.M., Lopipero,M., Smith,M., Blumenthal, R., Levinson,R., Berstein,L. and Ames,B.N. (1986) Chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1982. Environ. Hlth Perspect., 67, 161-200.
17. Gold,L.S., Slone,T.H., Backman,G.M., Magaw,R., DaCosta,M., Lopipero,P., Blumenthal,M. and Ames,B.N. (1987) Second chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986. Environ. Hlth Perspect., 74, 237-329.
18. Gold,L.S., Slone,T.H., Backman,G.M., Eisenberg,S., DaCosta,M., Wong,M., Manley,N.B, Rohrbach,L. and Ames,B.N. (1990) Third chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1986 and by the National Toxicology Program through June 1987. Environ. Hlth Perspect., 84, 215-286.
19. Gold,L S., Manely,N.B., Slone,T.H., Garfinkel,G.B., Rohrbach,L. and Ames,B.N. (1993) The fifth plot of the carcinogenic potency database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989. Environ. Hlth Perspect., 100, 65-135.
20. Han,X. and Liehr,J.G. (1992) Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res., 52, 1360-1363.
21. Hard,G.C. Iatropoulos,M.J , Jordan,K., Radi,L. Kaltenberg,O.P Imondi,A.R. and Williams,G.M. (1993) Major differences in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. Cancer Res., 53, 4534-4541.
22. Klopman,G. (1992) MULTICASE I. A hierarchical Computer Automated Structure Evaluation program. Quantit. Structure-Activity Relat., 11, 176-184.
23. Klopman,G. and Rosenkranz,H.S. (1994) Prediction of carcinogenicity/mutagenicity using MULTICASE. Mutat. Res., 305, 33-46.
24. Klopman,G., Dimayuga,M. and Talafous,J. (1994) META: 1. A program for the evaluation of metabolic transformations of chemicals. J. Chem. Informat. Comput. Sci., 34, 1320-1325.
25. Lerner,L.J., Jordan,V.C. (1990) Development of antiestrogens and their use in breast cancer: Eighth Cain Memorial Award Lecture. Cancer Res., 50, 4177-4189.
26. Lucier,G.W. (1992) Receptor-mediated carcinogenesis In Vamio,H., Magee,P.N., McGregor,D.B. and McMichael,A.J. (eds), Mechanisms of Carcinogenesis in Risk Identification, IARC Scientific Publication no. 116. International Agency for Research on Cancer, Lyon, pp. 87-112.
27. Miller,J.A. and Miller,E.C. (1977) Ultimate chemical carcinogens as reactive mutagenic electrophiles. In Hiatt,H.H., Watson,J.D. and Winsten,J.A. (eds). Origins of Human Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp. 605-627.
28. Montandon,F. and Williams,G.M. (1994) Comparison of DNA reactivity of the polyphenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liver. Arch. Toxicol., 68, 272-275.
29. National Academy of Sciences (1984) Toxicity Testing. Strategies to Determine Needs and Priorities. National Academy of Sciences Press. Washington, DC.
30. 50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments. Environ. Hlth Perspect., 58, 1-8.
31. Rosenkranz,H.S. (1992) Structure-activity relationships for carcinogens with differing modes of action. In Vainio,H., Magee,P.N., McGregor,D.B. and McMichael,A.J. (eds), Mechanisms of Carcinogenesis in Risk Identification, IARC Scientific Publication no. 116. International Agency for Research on Cancer, Lyon, pp. 271-277.
32. Rosenkranz,H.S. and Klopman,G. (1995) The application of structural concepts to the prediction of the carcinogenicity of therapeutic agents. In Wolff,M.E. (ed.), Burger's Medicinal Chemistry and Drug Discovery, vol. 1: Principles and Practice, 5th edn. John Wiley New York, NY, pp. 223-249.
33. Safe,S.H. (1995) Environmental and dietary estrogens and human health: Is there a problem? Environ. Hlth Perspect., 103, 346-351.
34. Scholl,S.M., Huff,K.F. and Lippman,M.E. (1983) Antiestrogenic effects of LY 117018 in MCF-7 cells. Endocrinology, 113, 611-617.
35. Shelby,M.D. (1988) The genotoxicity of human carcinogens and its implications Mutat. Res., 204, 3-15.
36. Talafous,J., Sayre,L.M., Mieyal,J.J. and Klopman,G. (1994) META: 2. A dictionary model of mammalian xenobiotic metabolism. J. Chem. Informat. Comput. Sci., 34, 1326-1333.
37. Vainio,H., Magee,P.N., McGregor,D.B. and McMichael,A.J. (eds) (1992) Mechanisms of Carcinogenesis in Risk Identification, IARC Scientific Publication no. 116. International Agency for Research on Cancer, Lyon, France.
38. White,I.N.H , DeMatteis,F., Davies,A., Smith,L.L, Crofton-Sleigh,C., Venitt,S., Hewer,A. and Phillips,D.H. (1992) Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. Carcinogenesis, 13, 2197-2203.
39. Williams,G.M., Iatropoulos,M.J., Djordjevic,M.V. and Kaltenberg,O.P. (1993) The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat. Carcinogenesis, 14, 315-317.